Stem cell transplantation for liver disease
Chen Xi,Yang Shi-zhong,Liu Qing-mei,Zhao Ying,Chi Bao-rong
DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.08.040
2008-01-01
Abstract:BACKGROUND: As for liver disease, conventional medical therapeutic efficacy is not good. Orthotopic liver transplantation is still the most effective measure for liver disease of terminal stage. But it is limited by lacking liver source, high cost, graft rejective reaction and complication caused by long-term immunodepressant. Stem cell transplantation will be good to recover damaged hepatic tissue and compensate some hepatic functions. It becomes a new method for liver disease. OBJECTIVE:To introduce the present research of stem cell transplantation for liver disease. RETRIEVAL STRATEGY:We searched in Pubmed for the literatures published from January 2002 to December 2007 with the of "transplantation of stem cell,liver disease,hepatic disease"in English. We also searched in CNKI for relevant articles published in the same period with the same key words in Chinese. 125 articles were selected and checked firstly. Inclusive criteria: ①The articles related to stem cell transplantation for liver disease, ②those published in the more authorized journals within recent years were preferred chosen as for the same field. Exclusive criteria: repeated investigation or Meta analysis papers. LITERATURE EVALUATION:The source of literature was mainly through collection and analysis of stem cell transplantation for liver disease. From those pieces we chosen, 36 articles focused highly on stem cell transplantation for liver disease, and 30 of which meet the criterion fully were used as reference for review. The full texts were searched firstly, 2 articles were review, and all the others were clinical or elementary empirical study. DATA SYNTHESIS:①Animal experiment of stem cell transplantation: Animal models of hepatic injury were constructed with different mothods, and then different kinds of stem cells were transplanted into model animals through different pathway. Histology of liver, aminotransferase, albumin and so on were assayed. Results showed that stem cell transplantation could improve liver function, repair damaged liver tissue, and relieve liver injury. ②Stem cell transplantation for clinical therapy: Many researches on liver disease of terminal stage and refractoriness indicated that after stem cell transplantation, symptom of patients relieved, and liver functions and blood clotting functions were improved. This measure could shorten time of therapy, improve prognosis and do not following with serious complication. ③Correlative complication and application evaluation of stem cell transplantation: The researches on stem cell transplantation for liver patients were not rational designed into multicentre, large sample and randomized controlled trial. Those therapeutic effects were not certain. Up to now different reports could be seen. Complications such as viral infection and hepatic venous obstruction appeared. As well as oncogenicity of stem cells, all these limited its application. CONCLUSION:Many clinical researches of liver patients with stem cell transplantation have acquired some therapeutic effect at present, but some reports believed this measure could not improve liver injury, and induce correlative complications and some questions. Clinical trials must to be rational designed. To ascertain the validity of previous findings by random controlled trials, it can be made as a safe and effective measure for liver disease. Thus issues on it could be excluded so that stem cell transplantation can be spread to clinical application.